Bharat Biotech
Bharat Biotech setting up four vaccine manufacturing facilities
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, on Monday said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per annum. Denying allegations that the city-based vaccine maker lacks data of Covaxin, Krishna Ella, chairman of Bharat […]
4 years ago#Northeast Live Digital Desk
Covaxin can work against mutated coronavirus: Bharat Biotech
Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krishna Ella said on Tuesday. He also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with […]
4 years ago